Maria Sharapova Ban: What Happened and Why
Maria Sharapova received a two-year ban from tennis after testing positive for meldonium at the 2016 Australian Open. The Court of Arbitration for Sport reduced the suspension to 15 months in October 2016, allowing her return to competition in April 2017. The ban stemmed from WADA's addition of meldonium to the prohibited list effective January 1, 2016, and Sharapova's admission that she had used the drug for health reasons over a decade. The case drew global attention to anti-doping compliance for professional athletes with long-established supplement routines. For more details on the original ruling, see the official CAS decision summary at https://www.tas-cas.org/en/decisions.
The ban cost Sharapova an estimated $30 million in lost prize money and endorsements during the suspension period. Her ranking dropped from No. 2 to outside the top 100 upon her return, and she lost contracts with major brands including Nike, Porsche, and Evian. Nike initially suspended its partnership in March 2016, while Porsche and Swiss watchmaker Tag Heuer paused campaigns. The financial impact highlighted the vulnerability of athlete income streams to anti-doping violations, a pattern seen across multiple sports. Additional context on endorsement losses in similar cases is available at https://www.forbes.com/sites/.
Maria Sharapova Ban Aftermath and Return to Tennis
Sharapova returned to the WTA tour in April 2017 and reached the French Open final the same year, losing to Jelena Ostapenko. She continued competing on tour through 2020, reaching the Australian Open final in 2018 and maintaining a top-20 ranking for parts of her comeback. Her on-court performance never fully returned to pre-ban levels, and she announced her retirement from professional tennis in February 2020. The retirement marked the end of a career that had produced five Grand Slam singles titles and a former world No. 1 ranking. Career statistics and rankings are tracked by the WTA at https://www.wtatennis.com/.
After retiring, Sharapova pivoted to business and investing, founding the candy brand Sugarpova and launching the investment firm Prime Time Ventures. She has focused on early-stage consumer brands and wellness companies, leveraging her global profile to build a post-tennis portfolio. The shift reflects a broader trend of retired athletes using brand equity to enter finance and entrepreneurship. Insights on athlete transitions into business are covered at https://www.forbes.com/sites/.
Maria Sharapova Ban Legacy and Current Status
The Maria Sharapova ban remains a reference point in anti-doping discussions, illustrating how regulatory changes can affect athletes who used approved substances before a ban. Her case contributed to WADA's review of meldonium and influenced how athletes disclose supplement use. The episode also prompted sports organizations to tighten supplement compliance protocols and education for players. The ongoing relevance of the case is visible in current WADA guidance documents and athlete education programs.
Today, Sharapova remains active in business and philanthropy through the Sharapova Foundation, which supports education and sports access for children. Her net worth, estimated at around $380 million by Forbes, places her among the wealthiest retired female athletes despite the financial hit from the ban. The combination of athletic achievement, scandal, and reinvention continues to shape public and media narratives around her career. Financial and career milestones are reported by Forbes at https://www.forbes.com/sites/.